A study on prescription patterns for migraine medications reveals gender and racial disparities in access to care. Men received more prescriptions for calcitonin gene-related peptide (CGRP) medications compared to women, potentially due to contraindications in pregnancy. White patients received more prescriptions than other racial groups, with a spike in Black patients in 2021. Non-Hispanic, non-Latino patients received more prescriptions than Hispanic or Latino patients. For gepants, women began receiving more prescriptions than men in 2021. Patients with lower incomes received fewer prescriptions for both types of medications. The researchers aim to address these disparities through further research and interventions.
Source link
Racial, Gender Inequities in CGRP, Gepant Prescriptions
